Emerald Health Therapeutics (EMH) Stock Price, News & Analysis

Company Overview

Emerald Health Therapeutics, Inc., together with its subsidiaries, produces and sells medical cannabis for medical purpose in Canada. The company is also involved in developing natural health products. It offers dried cannabis strains, pre-rolls, and cannabis oil products to its medical patients. The company was formerly known as T-Bird Pharma Inc. and changed its name to Emerald Health Therapeutics, Inc. in June 2015. Emerald Health Therapeutics, Inc. is headquartered in Vancouver, Canada.

Key Stats

• Today's Range: C$0.25 to C$0.27
• 50-Day Range: C$0.26 to C$0.26
• 52-Week Range: C$0.15 to C$0.53
• Volume: 384,329 shs
• Average Volume: 644,760 shs
• Market Capitalization: C$52.28 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

EMH Stock Analysis - Frequently Asked Questions

How have EMH shares performed this year?

Emerald Health Therapeutics' stock was trading at C$0.26 at the beginning of the year. Since then, EMH shares have increased by 0.0% and is now trading at C$0.26.

How do I buy shares of Emerald Health Therapeutics?

Shares of EMH stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.

What other stocks do shareholders of Emerald Health Therapeutics own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Emerald Health Therapeutics investors own include Aurora Cannabis (ACB), Alibaba Group (BABA), Meta Platforms (META), Advanced Micro Devices (AMD), Tesla (TSLA), Trulieve Cannabis (TCNNF) and Canopy Growth (WEED).

Industry, Sector and Symbol

• Stock Exchange: CVE
• Sector: Medical
• Industry: Biotechnology
• Sub-Industry: N/A
• Current Symbol: CVE:EMH
• CIK: N/A
• Web: www.emerald.care
• Phone: +1-250-8189838
• Fax: N/A
• Employees: 161
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: 35.45
• Current Ratio: 2.97
• Quick Ratio: 2.61

Sales & Book Value

• Annual Sales: C$13.02 million
• Price / Sales: 4.02
• Cash Flow: C$0.33 per share
• Price / Cash Flow: 0.78
• Book Value: C$0.40 per share
• Price / Book: 0.64

Miscellaneous

• Outstanding Shares: 205,028,000
• Free Float: N/A
• Market Cap: C$52.28 million
• Optionable: Not Optionable
• Beta: N/A